PPA
LYEL icon

Parametric Portfolio Associates’s Lyell Immunopharma LYEL Stock Holding History

Parametric Portfolio Associates’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$185K Buy
1,835
+1,096
+148% +$133K ﹤0.01% 3461
2021
Q4 		$114K Buy
+739
New +$165K ﹤0.01% 3534

Other funds holding LYEL

MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
A
Apoletto Road Town, Tortola, British Virgin Islands $260M AUM 31.4% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
HH
HSG Holding Na, Hong Kong $1.2B AUM 23.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Parametric Portfolio Associates's LYEL Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Lyell Immunopharma (LYEL) stake by 148% in Q1 2022, buying an estimated $133K and bringing the position to 1,835 shares worth $185K. The position accounts for ﹤0.01% of the portfolio, ranked #3461.

Parametric Portfolio Associates first reported a position in LYEL in Q4 2021 and has held it in 2 quarters since. 79 funds tracked by Wall St. Rank hold LYEL as of Q1 2022.

  • Parametric Portfolio Associates held 1,835 shares of Lyell Immunopharma worth $185K as of Q1 2022.
  • Parametric Portfolio Associates bought 1,096 Lyell Immunopharma shares in Q1 2022, an estimated $133K.
  • Lyell Immunopharma made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #3461 holding.
  • Parametric Portfolio Associates first reported a position in Lyell Immunopharma in Q4 2021 and has held it in 2 quarters since.
  • 79 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.